Amrize (NYSE:AMRZ) Sets New 52-Week Low - Time to Sell?

Key Points

• Amrize shares fell 2.1% to a new 52-week low of $43.67, below both their 50-day and 200-day moving averages. The decline followed quarterly earnings of $0.88 per share, which missed analysts’ $0.92 estimate.
• Analyst sentiment remains broadly positive but has weakened, with the stock carrying a “Moderate Buy” consensus rating and a $59.87 average price target. Recent views include Truist cutting its target to $48 and DA Davidson initiating coverage with a neutral rating and a $50 target.
• There are some supportive signals despite the selloff: insiders bought nearly $885,000 of stock last quarter, major institutions increased their positions, and Amrize recently paid a quarterly dividend of $0.11.

Amrize Ltd (NYSE:AMRZ - Get Free Report) shares reached a new 52-week low during trading on Monday . The company traded as low as $43.67 and last traded at $43.73, with a volume of 2983616 shares traded. The stock had previously closed at $44.67.

Analyst Ratings Changes

Several analysts have commented on AMRZ shares. Morgan Stanley set a $63.00 price target on Amrize and gave the company an "overweight" rating in a research note on Monday, June 22nd. Weiss Ratings raised Amrize from a "sell (d+)" rating to a "hold (c)" rating in a research note on Thursday, August 13th. Truist Financial reiterated a "hold" rating and issued a $48.00 price objective (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. DA Davidson assumed coverage on Amrize in a research note on Monday, August 24th. They issued a "neutral" rating and a $50.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Amrize in a research report on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Amrize currently has an average rating of "Moderate Buy" and a consensus price target of $59.87.

Amrize Stock Down 2.1%

The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The firm's fifty day moving average price is $49.51 and its 200-day moving average price is $53.75. The company has a market cap of $24.19 billion, a price-to-earnings ratio of 20.15, a price-to-earnings-growth ratio of 0.99 and a beta of 0.12.

Amrize (NYSE:AMRZ - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion for the quarter. Sell-side analysts predict that Amrize Ltd will post 2.74 earnings per share for the current year.

Amrize Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize's payout ratio is currently 20.28%.

Insider Buying and Selling at Amrize

In related news, insider Jaime Hill purchased 1,500 shares of Amrize stock in a transaction dated Tuesday, August 11th. The stock was bought at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the acquisition, the insider directly owned 29,698 shares of the company's stock, valued at $1,399,369.76. This represents a 5.32% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Roald Brouwer bought 1,500 shares of the stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $46.36 per share, with a total value of $69,540.00. Following the acquisition, the chief technology officer owned 21,490 shares in the company, valued at approximately $996,276.40. This represents a 7.50% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 18,983 shares of company stock worth $884,535 in the last quarter. Company insiders own 0.54% of the company's stock.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently bought and sold shares of the company. California State Teachers Retirement System lifted its position in shares of Amrize by 5,444.5% in the second quarter. California State Teachers Retirement System now owns 30,472,836 shares of the company's stock worth $1,624,202,000 after purchasing an additional 29,923,230 shares in the last quarter. Norges Bank bought a new position in Amrize in the fourth quarter valued at $929,333,000. Harris Associates L P acquired a new stake in Amrize in the 4th quarter valued at $615,406,000. Wellington Management Group LLP increased its stake in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Finally, Marshall Wace LLP lifted its position in Amrize by 865.4% during the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock worth $139,436,000 after buying an additional 2,590,336 shares in the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source